Prens E - Search Results

1

Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Sabat R, et al. Among authors: prens e. Nat Rev Dis Primers. 2020 Mar 12;6(1):18. doi: 10.1038/s41572-020-0149-1. Nat Rev Dis Primers. 2020. PMID: 32165620 Review.

2

The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.

van der Zee HH, Boer J, Prens EP, Jemec GB. van der Zee HH, et al. Among authors: prens ep. Dermatology. 2009;219(2):143-7. doi: 10.1159/000228337. Epub 2009 Jul 8. Dermatology. 2009. PMID: 19590174 Free article.

3

Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study.

van der Zee HH, van der Woude CJ, Florencia EF, Prens EP. van der Zee HH, et al. Among authors: prens ep. Br J Dermatol. 2010 Jan;162(1):195-7. doi: 10.1111/j.1365-2133.2009.09430.x. Epub 2009 Aug 14. Br J Dermatol. 2010. PMID: 19681876

4

Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions.

van der Zee HH, Prens EP, Boer J. van der Zee HH, et al. J Am Acad Dermatol. 2010 Sep;63(3):475-80. doi: 10.1016/j.jaad.2009.12.018. J Am Acad Dermatol. 2010. PMID: 20708472

5

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.

van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. van der Zee HH, et al. Among authors: prens ep. Br J Dermatol. 2011 Jun;164(6):1292-8. doi: 10.1111/j.1365-2133.2011.10254.x. Epub 2011 May 17. Br J Dermatol. 2011. PMID: 21332464

6

Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions.

van der Zee HH, de Ruiter L, Boer J, van den Broecke DG, den Hollander JC, Laman JD, Prens EP. van der Zee HH, et al. Among authors: prens ep. Br J Dermatol. 2012 Jan;166(1):98-106. doi: 10.1111/j.1365-2133.2011.10643.x. Epub 2011 Dec 5. Br J Dermatol. 2012. PMID: 21929531

7

Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.

Nazary M, van der Zee HH, Prens EP, Folkerts G, Boer J. Nazary M, et al. Among authors: prens ep. Eur J Pharmacol. 2011 Dec 15;672(1-3):1-8. doi: 10.1016/j.ejphar.2011.08.047. Epub 2011 Sep 14. Eur J Pharmacol. 2011. PMID: 21930119 Review.

8

The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa.

van der Zee HH, Prens EP. van der Zee HH, et al. Among authors: prens ep. Dermatology. 2011;223(2):169-73. doi: 10.1159/000332846. Epub 2011 Oct 13. Dermatology. 2011. PMID: 21997700 Clinical Trial.

9

Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.

van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP. van der Zee HH, et al. Among authors: prens ep. Br J Dermatol. 2012 Feb;166(2):298-305. doi: 10.1111/j.1365-2133.2011.10698.x. Br J Dermatol. 2012. PMID: 22013960

10

Is mechanical stress an important pathogenic factor in hidradenitis suppurativa?

de Winter K, van der Zee HH, Prens EP. de Winter K, et al. Exp Dermatol. 2012 Mar;21(3):176-7. doi: 10.1111/j.1600-0625.2012.01443.x. Exp Dermatol. 2012. PMID: 22379963 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page